BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
Champions Oncology Q4 2026 Earnings Call Transcript
Champions Oncology Q3 2026 Earnings Call Transcript
Full Transcript: Champions Oncology Q1 2027 Earnings Call
Full Transcript: Champions Oncology Q4 2026 Earnings Call
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ...
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
Champions Oncology, Inc. Q1 2027 Earnings Call Summary
Champions Oncology Q1 Earnings Call Highlights
Champions Oncology (NASDAQ:CSBR) Shares Jump as Q1 Margins Expand and Adjusted EBITDA Turns Higher
Champions Oncology Reports Revenue of $15.2 Million
Champions Oncology, Inc. (CSBR) Q1 2027 Earnings Call Transcript
Champions Oncology Q1 Adj. EPS $0.05 Up From $0.01 YoY, Sales $15.232M Up From $13.995M YoY
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
Champions Oncology Expands Radiopharmaceutical Platform With In-House SPECT/CT Imaging For Integrated Tumor Biology And Efficacy Insights
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
Champions Oncology Q4 Earnings Call Highlights
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.